Manning Paul B

Candel Therapeutics, Inc. ยท Director

Manning Paul B is listed in public filings as director. This Manning Paul B insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Candel Therapeutics, Inc. (CADL), Liquidia Corporation (LQDA), Verrica Pharmaceuticals Inc. (VRCA), and Taysha Gene Therapies, Inc. (TSHA). Investors use Manning Paul B's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Candel Therapeutics, Inc.CADL$23k4.6k sharesGrant / ExerciseMar 31, 2026$22.6K4.6k shares$4.90--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Candel Therapeutics, Inc.CADL$15M2.8M sharesBuyFeb 23, 2026$3.0M550.5k shares$5.45--
Liquidia CorporationLQDA$055.1k sharesOtherFeb 11, 2026$2.3M55.1k shares$42.63--
Verrica Pharmaceuticals Inc.VRCA$14M3.3M sharesBuyNov 25, 2025$11.7M2.8M shares$4.24--
Verrica Pharmaceuticals Inc.VRCA$17M4M sharesBuyNov 25, 2025$5.8M1.4M shares$4.24--
Verrica Pharmaceuticals Inc.VRCA$4.3M687.7k sharesBuyNov 25, 2025$4.3M687.7k shares$6.32--
Verrica Pharmaceuticals Inc.VRCA$2.2M343.8k sharesBuyNov 25, 2025$2.2M343.8k shares$6.32--
Liquidia CorporationLQDA$14M505.1k sharesSellSep 2, 2025$7.3M254k shares$28.67--
Liquidia CorporationLQDA$13M430.8k sharesSellSep 2, 2025$2.2M74.2k shares$29.14--
Liquidia CorporationLQDA$21M759.1k sharesSellAug 29, 2025$5.2M188.2k shares$27.62--
Liquidia CorporationLQDA$26M947.3k sharesSellAug 28, 2025$4.3M154.3k shares$27.94--
Candel Therapeutics, Inc.CADL$10M2.2M sharesGrant / ExerciseJun 25, 2025$5.0M1.1M shares$4.67--
Candel Therapeutics, Inc.CADL$70k14.2k sharesGrant / ExerciseJun 17, 2025$70.3K14.2k shares$4.94--
Taysha Gene Therapies, Inc.TSHA$7.8M2.8M sharesBuyMay 30, 2025$2.1M750k shares$2.75--
Candel Therapeutics, Inc.CADL$7.8M1.3M sharesBuyDec 16, 2024$4.5M750k shares$6.00--
Candel Therapeutics, Inc.CADL$6.9M1.1M sharesBuyDec 16, 2024$3.0M500k shares$6.00--
Verrica Pharmaceuticals Inc.VRCA--25.8M sharesGrant / ExerciseNov 26, 2024Disclosure amount unavailable450k shares----
Verrica Pharmaceuticals Inc.VRCA$23M26.3M sharesBuyNov 22, 2024$16.4M18.4M shares$0.89--
Verrica Pharmaceuticals Inc.VRCA$12M9.2M sharesBuyNov 22, 2024$12.3M9.2M shares$1.34--
Verrica Pharmaceuticals Inc.VRCA$9.8M9.2M sharesBuyNov 22, 2024$9.8M9.2M shares$1.07--
Verrica Pharmaceuticals Inc.VRCA$5.3M6M sharesBuyNov 22, 2024$4.0M4.5M shares$0.89--
Verrica Pharmaceuticals Inc.VRCA$3.0M2.2M sharesBuyNov 22, 2024$3.0M2.2M shares$1.34--
Verrica Pharmaceuticals Inc.VRCA$2.4M2.2M sharesBuyNov 22, 2024$2.4M2.2M shares$1.07--
Verrica Pharmaceuticals Inc.VRCA--2.7M sharesGrant / ExerciseSep 19, 2024Disclosure amount unavailable2.7M shares----
Verrica Pharmaceuticals Inc.VRCA--891.9k sharesGrant / ExerciseSep 19, 2024Disclosure amount unavailable891.9k shares----
Verrica Pharmaceuticals Inc.VRCA--891.9k sharesGrant / ExerciseSep 19, 2024Disclosure amount unavailable891.9k shares----
Taysha Gene Therapies, Inc.TSHA$3.0M1.3M sharesBuyJun 27, 2024$3.0M1.3M shares$2.25--
Candel Therapeutics, Inc.CADL$81k14.2k sharesGrant / ExerciseJun 26, 2024$81.3K14.2k shares$5.71--